Medicine and Dentistry
Transplantation
100%
Diabetes
82%
Infection
77%
Disease
58%
Liver Transplantation
49%
Systematic Review
42%
Meta-Analysis
37%
COVID-19
36%
Virus Infection
33%
Maturity Onset Diabetes of the Young
31%
Vitamin D
28%
Kidney Transplantation
27%
Primary Health Care
26%
Sepsis
24%
Kidney Graft
24%
Randomized Controlled Trial
23%
Pancreas Transplantation
23%
Cytomegalovirus
22%
Liver Graft
22%
Ebolavirus
22%
Acute Liver Failure
21%
Diagnosis
21%
Immunosuppressive Treatment
21%
Impaired Glucose Tolerance
20%
Diabetes Mellitus
19%
Malignant Neoplasm
19%
Prevalence
19%
Liver Disease
18%
Clinician
18%
Pathogen
18%
Intensive Care Unit
18%
Glycemic
17%
Ventilator-Associated Pneumonia
17%
Rheumatology
17%
Health Care
17%
Pediatrics
17%
Internal Medicine
17%
Insulin Dependent Diabetes Mellitus
16%
Solid Organ Transplantation
16%
Chronic Kidney Disease
15%
Quality of Life
15%
Hepatitis C
15%
Odds Ratio
15%
Rheumatoid Arthritis
14%
Hemoglobin A1c
14%
Cancer
14%
Antibiotics
14%
Cardiovascular Disease
14%
Drug Therapy
14%
Nonalcoholic Fatty Liver
14%
Clinical Trial
13%
Adverse Event
13%
Hyperglycemia
13%
Placebo
13%
Injury
13%
Patient Care
13%
Short Bowel Syndrome
13%
Surgery
13%
Health Care Cost
12%
Cohort Analysis
12%
Electronic Health Record
12%
Glycemic Control
12%
Supplementation
11%
Kidney Pancreas Transplantation
11%
Cytomegalovirus Infection
11%
Hypoglycemia
11%
Diabetes Prevention
11%
Neoplasm
11%
Systematized Nomenclature of Medicine
11%
Biological Marker
10%
Adenoviridae
10%
Liver Cirrhosis
10%
Diarrhea
10%
Nephropathy
10%
Hematopoietic Stem Cell Transplantation
10%
Interprofessional Education
9%
Hazard Ratio
9%
Differentiated Thyroid Cancer
9%
Medicine
9%
Thyroid Cancer
9%
Kidney Function
9%
Biocontainment
9%
Randomized Clinical Trial
9%
Mixed Infection
9%
Enteritis
8%
Disease Severity
8%
Nephrologist
8%
Cardiovascular Risk
8%
Graft Survival
8%
Antibiotic Therapy
8%
Awareness
8%
End Stage Liver Disease
8%
Neuroendocrine Tumor
8%
Hemodialysis
8%
Parenteral Nutrition
8%
Hepatocellular Carcinoma
8%
Body Mass Index
8%
Immunocompromised Patient
8%
Intensive Care
8%
Hepatitis B
8%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
65%
Infection
55%
Vitamin D
35%
Coronavirinae
32%
Non Insulin Dependent Diabetes Mellitus
28%
Placebo
26%
Adverse Event
26%
Remdesivir
24%
Sepsis
22%
Clinical Trial
17%
Randomized Controlled Trial
17%
Hemodialysis
17%
Acute Liver Failure
17%
Ventilator Associated Pneumonia
17%
Liver Disease
17%
Antibiotics
16%
Rheumatoid Arthritis
16%
Cholecalciferol
15%
Cohort Study
15%
Cardiovascular Disease
15%
Biological Marker
13%
Ebola Virus Disease
13%
Inflammation
12%
Nonalcoholic Fatty Liver
12%
Prevalence
12%
Ethanol
11%
Kidney Disease
11%
Cytomegalovirus Infection
11%
Malonaldehyde
10%
Hyperglycemia
10%
Antibiotic Agent
10%
Bile Acid
10%
Infectious Agent
10%
Cytomegalovirus
10%
Antiinfective Agent
10%
25 Hydroxyvitamin D
10%
Hepatitis C
9%
Injury
9%
Hepatitis C Virus
9%
Receptor
9%
Combination Therapy
9%
Tacrolimus
9%
Observational Study
9%
Community Acquired Pneumonia
9%
Procalcitonin
8%
Diseases
8%
Immunocompromised Patient
8%
Chronic Kidney Failure
8%
Virus Infection
8%
Hemoglobin A1c
8%
Mouse
8%
Impaired Glucose Tolerance
8%
Rapamycin
8%
Methotrexate
7%
Semaglutide
7%
Trimethylglycine
7%
Comorbidity
7%
Hypoglycemia
7%
Diarrhea
7%
Malignant Neoplasm
7%
Diabetes Mellitus
7%
Side Effect
6%
Dexamethasone
6%
Creatinine
6%
Adenoviridae
6%
Asialoorosomucoid
6%
Nephrotoxicity
6%
Metformin
6%
Liraglutide
6%
Vancomycin
6%
Thyroid Cancer
6%
Ursodeoxycholic Acid
6%
Valganciclovir
6%
Paracetamol
6%
Cardiovascular Risk
6%
Epitope
5%
Hydroxychloroquine
5%
SARS Coronavirus
5%
Insulin Resistance
5%
Biological Product
5%
Disease Transmission
5%
Prospective Cohort Study
5%
Thyroglobulin
5%
Baricitinib
5%
Elimination
5%
Cryptococcosis
5%
Liver Fibrosis
5%
Biocontainment
5%
Mortality Rate
5%
Monotherapy
5%
Steatosis
5%
Hospital Acquired Pneumonia
5%
Pharmacokinetics
5%
Actin
5%
Glucagon Like Peptide 1 Receptor Agonist
5%
Ascites
5%
Fatty Liver
5%
Keyphrases
Ethanol
21%
COVID-19
20%
Acetaldehyde
15%
Transplant Recipients
14%
Diabetes
12%
Vitamin D
12%
Intestinal Transplant
11%
Remdesivir
11%
Liver
11%
Solid Organ Transplant Recipients
10%
Rheumatoid Arthritis
9%
Risk Factors
9%
Glycoprotein
8%
Confidence Interval
8%
Type 2 Diabetes Mellitus (T2DM)
8%
Clinical Practice Guidelines
8%
Meta-analysis
8%
Covalent Binding
8%
Kidney Transplantation
7%
Short Bowel Syndrome
7%
Pancreas Transplantation
7%
Ebola Virus Disease
7%
Kidney Transplant
7%
Rheumatic Diseases
7%
Ethanol-induced Liver Injury
7%
Hepatocytes
6%
Rat Liver Slices
6%
Clinical Outcomes
6%
Rheumatology
6%
Adenovirus Disease
6%
Diabetes Management
6%
Type 1 Diabetes Mellitus (T1DM)
6%
Ventilator-associated Pneumonia
6%
Hospitalized Patients
6%
Glycemic Control
6%
Chronic Kidney Disease
5%
COVID-19 Pandemic
5%
Transplantation
5%
Ethanol Intake
5%
Solid Organ Transplantation
5%
Rat Hepatocytes
5%
Cryptococcosis
5%
Graduate Medical Education
5%
Interprofessional Education
5%
Liver Transplantation
5%
United States
5%
Pediatric
5%
Liver Slices
5%
Ethanol Oxidation
5%
Adult Patients
5%
First Year
5%
Receptor-mediated Endocytosis
5%
Cirrhosis
5%
Colchicine
5%
Hepatic Proteins
5%
Solid Organ Transplant
5%
Rat Liver
5%
Malondialdehyde-acetaldehyde Adducts
5%